IL4I1 and thyroid cancer: Here, this study reveals that the high level of IL4I1 promoted immune escape and predicted poor prognosis in thyroid cancer, which provides direction for future research into the novel target for immunotherapy, and diagnostic and unfavorable prognostic biomarker.